Does TAFASITAMAB Cause Covid-19? 96 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 96 reports of Covid-19 have been filed in association with TAFASITAMAB (MONJUVI). This represents 6.9% of all adverse event reports for TAFASITAMAB.
96
Reports of Covid-19 with TAFASITAMAB
6.9%
of all TAFASITAMAB reports
33
Deaths
57
Hospitalizations
How Dangerous Is Covid-19 From TAFASITAMAB?
Of the 96 reports, 33 (34.4%) resulted in death, 57 (59.4%) required hospitalization, and 8 (8.3%) were considered life-threatening.
Is Covid-19 Listed in the Official Label?
Yes, Covid-19 is listed as a known adverse reaction in the official FDA drug label for TAFASITAMAB.
What Other Side Effects Does TAFASITAMAB Cause?
Disease progression (470)
Diffuse large b-cell lymphoma (346)
Off label use (203)
Death (146)
Neutropenia (99)
General physical health deterioration (75)
Pneumonia (66)
Febrile neutropenia (64)
Drug ineffective (62)
Thrombocytopenia (60)
What Other Drugs Cause Covid-19?
NIRMATRELVIR\RITONAVIR (22,066)
OCRELIZUMAB (11,454)
ADALIMUMAB (9,138)
DUPILUMAB (6,986)
RITUXIMAB (6,301)
LENALIDOMIDE (6,223)
TOFACITINIB (4,926)
SECUKINUMAB (3,871)
INFLIXIMAB (3,698)
TACROLIMUS (3,201)
Which TAFASITAMAB Alternatives Have Lower Covid-19 Risk?
TAFASITAMAB vs TAFASITAMAB-CXIX
TAFASITAMAB vs TAFINLAR
TAFASITAMAB vs TAFLUPROST
TAFASITAMAB vs TAGRAXOFUSP-ERZS
TAFASITAMAB vs TAHOR